Reserved Menu


NAD project won the Second prize award in the section “Best Completed Project Contest”

during the award ceremony that took place at Conference Dinner of Industrial Technologies 2014 Conference 2014 on April 10th, 2014


The prize was given to Massimo Masserini, coordinator of NAD project, by Clara de la Torre,

Director responsible for "Research and Innovation" in the European Commission

The success story about NAD project is online on the H2020 website


The NAD project is also mentioned in the brochure that President Barroso sent to the Heads of Government, in advance of European Council Summit

See brochure: Horizon 2020: boosting industrial competitiveness with NAD on page 5.





The NAD (Nanoparticles for therapy and diagnosis of Alzheimer's disease) Project is aiming to
develop nanoparticles for Alzheimer's diagnosis and therapy.
Recent statistics  estimate that 24.3  million people have  dementia today, with 4.6 million  new  cases of dementia
every  year  (one new case every  7 seconds). In the EU, about 5 million people have dementia,with Alzheimer’s
disease (AD) accounting for over 3 million.
The goal of the study, developed in the field of nanotechnologies, is to create nanoparticles (NPs)able
to cross the blood-brain barrier to reach the brain, principal site of Alzheimer's disease. Molecules that
can recognize (diagnosis) and destroy (therapy) the amyloid deposits, characteristic of the illness,  will be
attached to the  nanoparticles, and tested on animal models of the disease (transgenic mice).  If the
expectations of the research are attained, future experiments can be performed on humans.
The results  can have an  enormous  impact on the  early  diagnosis and  therapy of  a disease of high
incidence, which takes a heavy social cost.
The  NAD  project  involves  19  European  research  centers of  13  European  countries (Italy,France,
Slovakia, Sweden, Netherlands, Hungary, Finland, Greece, Belgium, Spain, United Kingdom, Portugal,
and Denmark)
Research area: NMP-2007-4.0-4 Substantial innovation in the European medical industry:
development of nanotechnology-based systems for in-vivo diagnosis and therapy
(in coordination with topic HEALTH-2007-2.4.1-7 and HEALTH-2007-1.2-3 in Theme 1 "Health")
Prof. Masserini of University of Milano-Bicocca is the scientific coordinator of the project.